<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A lot of clinicians use <z:chebi fb="5" ids="28304">heparin</z:chebi> in patients with posterior circulation <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Frequency and risk factors of symptomatic intracerebral <z:mp ids='MP_0008817'>hematoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e>) in posterior circulation <z:mpath ids='MPATH_124'>infarct</z:mpath> patients anticoagulated with unfractionated <z:chebi fb="5" ids="28304">heparin</z:chebi> are not known </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: To determine the incidence and the risk factors of the <z:chebi fb="5" ids="28304">heparin</z:chebi>-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> in posterior circulation <z:mpath ids='MPATH_124'>infarct</z:mpath> patients, we retrospectively reviewed the clinical features of 37 patients who had <z:hpo ids='HP_0011009'>acute</z:hpo> posterior circulation <z:mpath ids='MPATH_124'>infarct</z:mpath> and received intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi> after they underwent brain computed tomographic scans and diffusion-weighted imaging (DWI) </plain></SENT>
<SENT sid="3" pm="."><plain>Follow-up brain scans were obtained at any time if clinical symptoms worsened </plain></SENT>
<SENT sid="4" pm="."><plain>Volumes of <z:hpo ids='HP_0011009'>acute</z:hpo> posterior circulation infarction were calculated on DWI </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Of 37 patients, four (10.8%) developed symptomatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> during <z:chebi fb="5" ids="28304">heparin</z:chebi> infusion </plain></SENT>
<SENT sid="6" pm="."><plain>The location of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> was cerebellum in <z:hpo ids='HP_0000001'>all</z:hpo> the hemorrhagic worsening patients </plain></SENT>
<SENT sid="7" pm="."><plain>We found that the size of an <z:hpo ids='HP_0011009'>acute</z:hpo> infarction calculated on DWI is the risk factor of symptomatic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICH</z:e> during intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy in patients with posterior circulation <z:mpath ids='MPATH_124'>infarct</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Until a large prospective study is performed, it may be prudent to avoid <z:chebi fb="5" ids="28304">heparin</z:chebi> infusion in patients with large posterior circulation <z:mpath ids='MPATH_124'>infarct</z:mpath> documented on DWI </plain></SENT>
</text></document>